Viaggi per imprenditori nel mercato target Viaggi per imprenditori legati a un tema o a un settore e personalizzati per ampliare la vostra rete nel mercato target.
Voyages de prospection sur le marché cible Voyages de prospection thématiques ou sectoriels, en groupe ou individuels, pour élargir votre réseau sur le marché cible.
Business travel in the target market Individualized and group business trips on specific topics or industries to expand your network in the target market.
Unternehmerreisen im Zielmarkt Themen- oder branchenspezifischen und individualisierte Unternehmerreisen zur Erweiterung Ihres Netzwerks im Zielmarkt.
Viaggi per imprenditori Viaggio di prospezione in Armenia: Business Forum 2024 BERS & SWISS Days 13 Mag 2024–16 Mag 2024 Armenia
Unternehmerreisen Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mag 2024–16 Mag 2024 Armenia
News 10 Ott 2023 HES-SO Valais-Wallis and Debiopharm partner up to battle cancer HES-SO Valais-Wallis and Debiopharm have entered a partnership to advance targeted cancer therapy research with novel antibody conjugates.
Actualités 10 Ott 2023 La HES-SO Valais-Wallis et Debiopharm s’associent pour lutter contre le cancer La HES-SO Valais-Wallis et Debiopharm ont conclu un partenariat pour faire progresser la recherche sur la thérapie ciblée contre le cancer avec d...
Fact-Finding Mission Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mag 2024–16 Mag 2024 Armenia
Voyages pour PME Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mag 2024–16 Mag 2024 Armenia
News 10 Gen 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Actualités 10 Gen 2024 L’essor remarquable de la chimie-pharma dans le canton du Valais Depuis des décennies, le canton du Valais a cultivé une réputation d’excellente dans les domaines de la chimie et de la pharmaceutique, fusionnan...
S-GE Event Today's infrastructure for tomorrow's sustainable development 17 Gen 2024 14:00–16:30 Davos Svizzera
News 31 Ott 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News 11 Ott 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
Actualités 31 Ott 2023 Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais Debiopharm Research & Manufacturing a annoncé un investissement de plus de CHF 30 millions dans l’agrandissement de son laboratoire de Martigny, ...
News 04 Ott 2023 Atinary Technologies raises USD 5 million to accelerate material and molecular innovation Vaud-based machine learning specialist Atinary Technologies has raised USD 5 million, propelling the start-up towards a new era of material and m...
News 10 Ott 2023 Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing Propelling the momentum towards humane, next-gen laboratory solutions, Nagi Bioscience has secured CHF 12.4 million to open doors to new markets ...
